ConditionGastro Esophageal Reflux
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorMidwest Veterans' Biomedical Research Foundation
About this trial
This will be a randomized clinical trial examining the efficacy and safety of ARAT (intervention group) in patients with chronic GERD symptoms (typical symptoms of GERD, i.e. heartburn or acid reflux/regurgitation at least twice a week) for the last 6 months.
Patients must have a positive pH test and a negative manometry (no treatment) procedure.
Eligibility criteria
Qualifiers
Chronic GERD symptoms (at least 1 typical symptom of GERD, i.e. heartburn or acid reflux/regurgitation at least twice a week) for last 6 months
Objective evidence of reflux disease (positive ambulatory pH study.)
Disqualifiers
Patients unable to or unwilling to participate or consent.
Age <18 years or >80 years.
Allergic or intolerant to PPI medications.
Large hiatal hernia > 3 cm and Hill grade IV.
Trial design
Treatments tested in this trial
- ARAT
- Sham intervention (control)
Treatment groups
36 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov